Effects of posterior vitreous detachment on aqueous humour levels of VEGF and inflammatory cytokines

British Journal of Ophthalmology

Volumn 99, Issue 8, 2015, Pages 1065-1069

  Takahashi, Hidenori ^a,b,c   Nomura, Yoko ^a   Tan, Xue ^a   Fujino, Yujiro ^c   Kawashima, Hidetoshi ^b   Yanagi, Yasuo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c KYUSHU HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL13 CHEMOKINE; CYTOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; AQUEOUS HUMOR; ARTICLE; B SCAN; CATARACT EXTRACTION; COMPARATIVE STUDY; CONTROLLED STUDY; ECHOOCULOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE AXIS LENGTH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ULTRASOUND SCANNER; VITREOUS BODY DETACHMENT; METABOLISM; PATHOPHYSIOLOGY; POSTERIOR EYE SEGMENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; AXIAL LENGTH, EYE; CATARACT EXTRACTION; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; POSTERIOR EYE SEGMENT; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS DETACHMENT;

EID: 84938747672     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2014-306051     Document Type: Article

References (25)

1. Weber-Krause B, Eckardt U. [Incidence of posterior vitreous detachment in eyes with and without age-related macular degeneration. An ultrasonic study]. Ophthalmologe 1996;93:660-5.
2. Ondes F, Yilmaz G, Acar MA, et al. Role of the vitreous in age-related macular degeneration. Jpn J Ophthalmol 2000;44:91-3.
3. Quaranta-El Maftouhi M, Mauget-Faysse M. Anomalous vitreoretinal adhesions in patients with exudative age-related macular degeneration: an OCT study. Eur J Ophthalmol 2006;16:134-7.
4. Krebs I, Brannath W, Glittenberg C, et al. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol 2007;144:741-6.
5. Robison CD, Krebs I, Binder S, et al. Vitreomacular adhesion in active and end-stage age-related macular degeneration. Am J Ophthalmol 2009;148:79-82.
6. Nomura Y, Ueta T, Iriyama A, et al. Vitreomacular interface in typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Ophthalmology 2011;118:853-9.
7. Mojana F, Cheng L, Bartsch DU, et al. The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol 2008;146:218-27.
8. Lee SJ, Koh HJ. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. Ophthalmology 2011;118:101-10.
9. Mayr-Sponer U, Waldstein SM, Kundi M, et al. Influence of the Vitreomacular Interface on Outcomes of Ranibizumab Therapy in Neovascular Age-related Macular Degeneration. Ophthalmology 2013;120:2620-9.
10. Uney GO, Unlu N, Acar MA, et al. Role of posterior vitreous detachment on outcome of anti-vascular endothelial growth factor treatment in age-related macular degeneration. Retina 2014;34:32-7.
11. Nomura Y, Takahashi H, Tan X, et al. Effects of vitreomacular adhesion on ranibizumab treatment in Japanese patients with age-related macular degeneration. Jpn J Ophthalmol 2014;58:443-7.
12. Simpson AR, Petrarca R, Jackson TL. Vitreomacular adhesion and neovascular age-related macular degeneration. Surv Ophthalmol 2012;57:498-509.
13. Quiram PA, Leverenz VR, Baker RM, et al. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina 2007;27:1090-6.
14. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
15. Mo FM, Proia AD, Johnson WH, et al. Interferon gamma-inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration. Invest Ophthalmol Vis Sci 2010;51:4226-36.
16. Fujimura S, Takahashi H, Yuda K, et al. Angiostatic effect of CXCR3 expressed on choroidal neovascularization. Invest Ophthalmol Vis Sci 2012;53:1999-2006.
17. Noma H, Funatsu H, Mimura T, et al. Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion. Eur J Ophthalmol 2010;20:402-9.
18. Takeda A, Baffi JZ, Kleinman ME, et al. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 2009;460:225-30.
19. Silveira AC, Morrison MA, Ji F, et al. Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach. Vision Res 2010;50:698-715.
20. Spinetti G, Camarda G, Bernardini G, et al. The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells. Biochem Biophys Res Commun 2001;289:19-24.
21. Agawa T, Usui Y, Wakabayashi Y, et al. Profile of intraocular immune mediators in patients with age-related macular degeneration and the effect of intravitreal bevacizumab injection. Retina 2014;34:1811-18.
22. Yamada K, Sakurai E, Itaya M, et al. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. Invest Ophthalmol Vis Sci 2007;48:1839-43.
23. Terao R, Yuda K, Kure K, et al. Effect of vitreomacular adhesion on antivascular endothelial growth factor therapy for macular edema secondary to branch retinal vein occlusion. Jpn J Ophthalmol 2014;58:139-45.
24. Sebag J, Ansari RR, Suh KI. Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients. Graefes Arch Clin Exp Ophthalmol 2007;245:576-80.
25. Stefansson E, Loftsson T. The Stokes-Einstein equation and the physiological effects of vitreous surgery. Acta Ophthalmol Scand 2006;84:718-19.